Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Erasmus Medical Center, Rotterdam
3D echocardiography can aid selecting a pacing site in resynchronization therapy
November 6th, 2004
Researchers have reported on a feasibility study into guiding and optimization of resynchronization therapy with dynamic three-dimensional echocardiography and segmental volume-time curves. According to published research from Netherlands, "Resynchronization therapy for heart failure provides the greatest hemodynamic benefit when applied to the most delayed left ventricular (LV) site. Currently, the ideal LV pacing site is selected according to acute invasive hemodynamic assessment and/or tissue Doppler imaging." B.J. Krenning and colleagues of the Erasmus Medical Center in Rotterdam described their study, "A total of 16 patients with advanced heart...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2004-11-06)
|
